J R Soc Med 2004;97:472-476
doi:10.1258/jrsm.97.10.472
© 2004 Royal Society of Medicine
Achilles tendinopathy: aetiology and management
Nicola Maffulli MD FRCS (Orth)
Pankaj Sharma MRCS
Karen L Luscombe FRCS
Department of Trauma and Orthopaedic Surgery, Keele University School of
Medicine, Thornburrow Drive, Hartshill, Stoke-on-Trent ST4 7QB, UK
Correspondence to: Professor Nicola MaffulliE-mail:
n.maffulli{at}keele.ac.uk
 |
INTRODUCTION
|
|---|
In the past three decades, the incidence of Achilles tendinopathy
has risen
as a result of greater participation in recreational
and competitive sporting
activities.
1,2
The rate of Achilles
tendon injuries in runners is about ten times that in
age-matched
controls. Achilles tendinopathy is also common among athletes
participating
in racquet sports, track and field, volleyball and soccer.
However,
the condition is by no means confined to athletes: in one series
of
58 patients, nearly one-third did not participate in vigorous
physical
activity.
3
 |
ANATOMY
|
|---|
The Achilles tendon is a confluence of the gastrocnemius and
soleus
muscles. The soleus muscle lies deep to the gastrocnemius
muscle, arising from
the posterior surface of the upper tibia.
The tendon is inserted on the
posterior surface of the calcaneus
distal to the posterior-superior calcaneal
tuberosity. The Achilles
tendon is not encased in a true synovial sheath but
is surrounded
by paratendon composed of a single layer of cells. This tissue
is
richly vascularized and is responsible for much of the blood
supply,
4 which
reaches the tendon through a series of transverse vincula
that function as
passageways for the vessels. The Achilles tendon
also receives blood from
vessels originating at the musculotendinous
and osteotendinous junctions.
At about 1215 cm proximal to its insertion, rotation of the tendon
begins, becoming more marked in the distalmost 56 cm. The tendon
spirals approximately 90°, with the medial fibres rotating posteriorly and
the posterior fibres rotating laterally. Angiographic injection techniques
have demonstrated a zone of hypovascularity 27 cm proximal to the
tendon insertion. Additionally, the number of intratendinous vessels and the
relative area occupied by these vessels is lowest 4 cm from the calcaneal
insertion.4
Healthy tendons are brilliant white, with a fibroelastic texture. Within
the extracellular matrix network, tenoblasts and tenocytes constitute
9095% of the cellular elements of tendons. The remaining 510%
consists of fibrochondrocytes, synovial cells of the tendon sheath,
endothelial cells and smooth muscle cells. Collagen type 1 accounts for
6580% and elastin accounts for about 2% of the dry mass of tendons.
Tenocytes and tenoblasts lie between the collagen fibres along the long axis
of the tendon.5
Tendon innervation originates from three main sourcescutaneous,
muscular and peritendinous nerve trunks. At the musculotendinous junction,
nerve fibres cross and enter the endotenon septa. Nerve fibres from rich
plexuses in the paratenon penetrate the epitenon. Most nerve fibres do not
actually enter the main body of the tendon but terminate as nerve endings on
its surface. Nerve endings of myelinated fibres function as specialized
mechanoreceptors to detect changes in pressure or tension. Unmyelinated nerve
endings act as nociceptors, sensing and transmitting pain. Both sympathetic
and parasympathetic fibres have been
identified.6
Autonomic peptides such as neuropeptide Y and vasoactive intestinal peptide,
which regulate vasoactivity, have been demonstrated in
tendons.6,7
 |
BIOMECHANICS
|
|---|
Tendons transmit force generated by muscle to bone. Additionally,
they act
as a buffer by absorbing external forces to limit muscle
damagea
function that demands mechanical strength, flexibility
and
elasticity.
5 As
collagen fibres deform, they respond linearly
to increasing tendon
loads.
8 The
configuration is initially
lost when the stretch exceeds 2% but is regained if
the strain
placed on the tendon remains at less than 4%; if strain exceeds
8%
macroscopic rupture will
occur.
9,10
The tensile strength
of tendons is related to thickness and collagen content,
and
a tendon with a cross-sectional area of 1 sq cm is capable of
supporting
5001000 kg. Loading of the Achilles tendon
reaches up to 9 kN during
running (corresponding to 12.5 times
the body weight), 2.6 kN during slow
walking, and less than
1 kN during
cycling.
11
 |
AETIOLOGY AND PATHOPHYSIOLOGY
|
|---|
Tendon injuries can be acute or chronic. Clearly, in acute trauma
extrinsic
factors predominate, whereas in chronic disorders
intrinsic and extrinsic
factors commonly
interact.
12,13
Examples
of intrinsic factors are tendon vascularity,
gastrocnemiussoleus
dysfunction, age, gender, body weight and height,
pes cavus,
and lateral ankle instability. Excessive motion of the hindfoot
in
the frontal plane, especially a lateral heel strike with
compensatory
pronation, is thought to cause a whipping
action on the Achilles
tendon and predispose it to tendinopathy.
Also, forefoot varus is frequent in
patients with Achilles tendinopathy.
Extrinsic factors that may predispose to
Achilles tendinopathy
in athletes are changes in training pattern, poor
technique,
previous injuries, footwear and training on hard, slippery or
slanting
surfaces.
2,9
Excessive
loading of tendons during vigorous physical training is regarded
as
the main pathological stimulus for
degeneration.
2
Tendons
respond to repetitive overload beyond physiological threshold
by
inflammation of their sheath, degeneration of their body,
or a combination of
the two.
14 Whether
different stresses induce
different responses remains unclear. Active repair
of fatigue
damage must occur, or tendons would weaken and eventually rupture.
The
repair mechanism is probably mediated by resident tenocytes
that
continually monitor the extracellular matrix. Failure to
adapt to recurrent
excessive loads results in the release of
cytokines, leading to further
modulation of cell
activity.
15 Tendon
damage may even result from stresses within physiological
limits, since
frequent microtrauma may not allow enough time
for
repair.
2 Microtrauma
can also result from non-uniform stress
within tendons, producing abnormal
load concentrations and frictional
forces between the fibrils, with localized
fibre damage.
15
The aetiology of tendinopathy remains uncertain and many factors have been
implicated,1
including free radical damage occurring on reperfusion after ischaemia,
hypoxia, hyperthermia and impaired tenocyte
apoptosis.16 In
animals, tendinopathy can be induced by local administration of cytokines and
prostaglandins.17
Fluoroquinolones have also been implicated: ciprofloxacin enhances
interleukin-1 ß mediated release of matrix metalloproteinase (MMP3)
release, inhibits tenocyte proliferation and reduces collagen and matrix
synthesis.18
Changes in the expression of genes regulating cellcell and
cellmatrix interactions have been reported, with down-regulation of
MMP3 mRNA in tendinopathic Achilles tendon
samples.19 Type I
and type III collagen mRNAs have been found at higher levels in tendinopathic
samples than in normal
samples.19 In
tendinopathic Achilles tendons, upregulation of MMP2 and vascular endothelial
growth factor has been described, whilst MMP3 was
downregulated.20
Imbalance in MMP activity in response to repeated injury or mechanical strain
may result in tendon degeneration.
The main symptom of Achilles tendinopathy is pain, but again the underlying
mechanism is not fully understood. In the past it was assumed to arise through
inflammation or via collagen fibre separation or
degeneration,21,22
but chronically painful Achilles tendons show no evidence of inflammation, and
some that show clear intratendinous defects on MRI or ultrasound are not
painful.2124
Since tendinopathies are degenerative rather than inflammatory conditions,
pain may originate from a combination of mechanical and biochemical
factors.23
Microdialysis sampling revealed twofold higher lactate levels in tendinopathic
tendons than in controls. High concentrations of the neurotransmitter
glutamate, but no increase in the proinflammatory prostaglandin
PGE2, have been found in Achilles and patellar
tendinopathy.24
Several studies have confirmed the occurrence of sensory neuropeptides in
both animal and human tendons, and substance P has been found in tendinopathic
Achilles
tendons.7,25
Endogenous opioids provide a peripheral antinociceptive system, and morphine
inhibits the release of substance P from peripheral sensory nerve
endings.26 Under
normal conditions, a balance probably exists between nociceptive and
antinociceptive peptides.
 |
HISTOPATHOLOGY
|
|---|
The pathological label tendinosis is used for
the
disorganized healing response, but most clinicians still
use the term
tendinitis (or tendonitis), with its implication
that the condition is
essentially inflammatory. We recommend
use of the term
tendinopathy as a generic descriptor
of the clinical conditions
in and around tendons arising from
overuse, with tendinosis and tendinitis
being applied only after
histopathological
examination.
27
Histologically, tendinopathy is characterized by an absence of inflammatory
cells and a poor healing response, with non-inflammatory intratendinous
collagen degeneration, fibre disorientation and thinning, hypercellularity,
scattered vascular ingrowth, and increased interfibrillar
glycosaminoglycans.8,12,15
Frank inflammatory lesions and granulation tissue, when they occur, are
associated mainly with tendon
ruptures.28 Various
types of degeneration may be seen in tendons, but in the Achilles tendon the
usual types are mucoid and
lipoid.28 In mucoid
degeneration (i.e. proteoglycan/glycosaminoglycan accumulation in the tendon)
light microscopy reveals large mucoid patches and vacuoles between fibres.
Lipoid degeneration is characterized by abnormal intratendinous accumulation
of lipid, with disruption of collagen fibre
structure.8
Paratendinopathy may occur alone or in combination with degeneration of the
tendon body.29
Histologically, mucoid degeneration, fibrosis and vascular proliferation with
a slight inflammatory infiltrate have been
reported.13,30,31
Clinically, oedema and hyperaemia of the paratenon are seen. A fibrinous
exudate accumulates within the tendon
sheath.23
 |
CLINICAL PRESENTATION
|
|---|
The cardinal symptom of Achilles tendinopathy is pain. Generally
it occurs
at the beginning and end of a training session, with
a period of diminished
discomfort in between. As the pathological
process progresses, pain may occur
during exercise, and, in
severe cases, it can interfere with activities of
daily living.
In the acute phase, the tendon is diffusely swollen and
oedematous,
and on palpation tenderness is usually greatest 26 cm
proximal
to the tendon insertion (
Figure
1). Sometimes, fibrin precipitated
from the fibrinogen-rich fluid
around the tendon can result
in palpable
crepitation.
1,8,10
In chronic cases, exercise-induced
pain is still the cardinal symptom, while
crepitations and effusions
diminish.
8 A tender,
nodular swelling is usually present in chronic cases
and is believed to
signify
tendinosis
10.
The diagnosis of Achilles tendinopathy is based mainly on history and
detailed clinical examination. However, diagnostic imaging may be required to
verify a clinical suspicion or, occasionally, to exclude other musculoskeletal
disorders.8
 |
IMAGING METHODS
|
|---|
Ultrasonography is commonly employed to examine tendon disorders,
being
readily available, quick, safe and inexpensive. However,
it is
operator-dependent, offers limited soft-tissue contrast
and is less sensitive
than
MRI.
8,32
In acute cases, ultrasound
reveals fluid accumulation around the tendon
(
Figure 2). In
chronic cases,
peritendinous adhesions may be shown by thickening
of the hypoechoic paratenon
with poorly defined borders. A simple
grading system has been devised for
tendinopathy: grade 1 represents
a normal tendon; grade 2 an enlarged tendon;
and grade 3 a tendon
containing a hypoechoic
area.
33 Hypoechoic
areas can be nodular,
diffuse or multifocal, and correlate well with
macroscopic findings
at surgery. MRI provides extensive information on the
internal
morphology of tendon and the surrounding structures, and is
useful to
evaluate various stages of chronic degeneration and
for differentiation
between peritendinitis and tendinosis. An
excellent correlation has been
reported between MRI and pathological
findings at
surgery.
34

View larger version (94K):
[in this window]
[in a new window]
|
Figure 2. Axial ultrasound image demonstrating swelling of the Achilles tendon
with surrounding fluid accumulation
|
|
A longitudinal ultrasound study has indicated mild-to-moderate changes in
both involved and uninvolved Achilles tendons, but the occurrence of these
changes was not clearly related to the patients
symptoms.35 In view
of the high sensitivity of these imaging modalities, an abnormality should be
interpreted with caution and related to the patients symptoms before
any recommendations are made on
management.12
 |
MANAGEMENT
|
|---|
In the early phase of Achilles tendinopathy, conservative treatments
are
customary.
13,3537
Individuals who seek early advice
may have the best outcomes, since treatment
of the chronic condition
is more complex and
uncertain.
18,31
Surgical management is recommended
for patients who do not adequately respond
to a conservative
treatment programme over three to six
months.
13,30,34,36
The initial conservative programme is directed towards presumed
aetiological factors or towards relieving
symptoms.39 The
strategies include abstention from the activities that caused the symptoms and
correction of training errors, foot malalignments and muscle
weakness.39
Decreasing the intensity, frequency and duration of the activity that
caused the injury, or modification of that activity, may be the only action
necessary to control symptoms in the acute phase. Since collagen repair and
remodelling is stimulated by tendon loading, complete rest of an injured
tendon can be detrimental. Modified rest, reducing activity at the injured
site but allowing normal activity elsewhere, has been
recommended.8,39
Cryotherapy has been regarded as a useful intervention in the acute phase of
Achilles tendinopathy: it has an analgesic effect, reduces the metabolic rate
of the tendon and decreases extravasation of blood and protein from the new
capillaries found in tendon
injuries.8
Therapeutic ultrasound may reduce the swelling in the acute inflammatory phase
and improve tendon
healing.40
Ultrasound stimulates collagen synthesis in tendon fibroblasts and stimulates
cell division during periods of rapid cell
proliferation.41
Deep friction massage has been advocated for tendinopathy and
paratendinopathy. In chronic cases, this should be accompanied by stretching
to restore tissue elasticity and reduce the strain in the muscletendon
unit with joint motion. Augmented soft tissue mobilization is a
new non-invasive technique that has been used with success in chronic
tendinopathy, probably through controlled infliction of microtrauma with
resultant fibroblast
proliferation.42
Stretching and strengthening of the triceps surae muscle and Achilles tendon
are important to preserve function of the musculotendinous unit, restore
normal ankle joint mobility and decrease the strain on the Achilles tendon
with normal motion. Eccentric muscle training is superior to concentric
training in decreasing pain in chronic Achilles tendinopathy, and promising
results have been obtained with an intensive heavy-load training
regimen.43
If foot alignment is abnormal, orthoses that place the hindfoot in neutral
may prove beneficial. A heel lift of 1215 mm is typically used as an
adjunct to management of Achilles tendon
pain.37 Orthotics
correction can alter the biomechanics of the foot and ankle and relieve heel
pain. In runners orthotics have been used with up to 75%
success.44
Several drugs including low-dose heparin, Wydase (hyaluronidase) and
aprotinin have been used in the management of peritendinous and intratendinous
disease,45,46
but evidence of their long-term effectiveness is still lacking. Peritendinous
injections of corticosteroids are controversial and there are no good
scientific reasons to support their
use.47
Intratendinous injections of corticosteroids are likewise to be
avoided47.
In 2445.5% of patients with Achilles tendinopathy, conservative
management is unsuccessful and surgery has to be considered. The objective is
to excise fibrotic adhesions, remove degenerate nodules and make longitudinal
incisions in the tendon so as to detect intratendinous lesions and restore
vascularity (and possibly stimulate the remaining viable cells to initiate
cell matrix response and
healing).3,14,31
Multiple longitudinal tenotomies have been shown to trigger neoangiogenesis at
the Achilles tendon, with increased blood
flow.48 This should
improve nutrition and provide a more favourable environment for healing.
Patients are encouraged to weight-bear as soon as possible after surgery.
Researchers report excellent or good results in up to 85% of cases but
success rates are not always so high in routine non-specialized clinical
practice.38,49
It is difficult to compare the results of studies as most workers do not
report their assessment
procedure.49 Also,
no prospective randomized studies comparing operative and conservative
treatment of Achilles tendinopathy have been published, and most of our
knowledge on treatment efficacy comes from clinical experience and descriptive
studies.
 |
CONCLUSIONS
|
|---|
Although Achilles tendinopathy has been extensively studied,
there is much
to be learned about its aetiology, pathology and
optimal management. Most
patients respond to conservative measures
if the condition is recognized
early; continuation of the offending
activities leads to chronic changes that
are more resistant
to non-operative management. For many patients, control of
the
symptoms is a more realistic aim than complete cure.
 |
REFERENCES
|
|---|
- Kvist M. Achilles Tendon Overuse Injuries.
[PhD Thesis]. Turku: University of Turku, Finland,1991
- Selvanetti ACM, Puddu G. Overuse tendon injuries: basic science and
classification. Operative Techniques Sports Med1997; 5:110
17
- Rolf CMT. Etiology, histopathology, and outcome of surgery in
achillodynia. Foot Ankle Int1997; 18:565
9[Medline]
- Carr AJ, Norris SH. The blood supply of the calcaneal tendon.
Bone Joint Surg1989; 71:100
1
- Kirkendall DT, Garrett WE. Function and biomechanics of tendons.
Scand J Med Sports1997; 7:62
6
- Ackermann PW, Jian L, Finn A, Ahmed M, Kreicbergs A. Autonomic
innervation of tendons, ligaments and joint capsules: a morphologic and
quantitative study in the rat. J Orthopaed Res2001; 19:372
8[Medline]
- Ljung BO, Forsgren S, Friden J. Sympathetic and sensory
innervations are heterogeneously distributed in relation to the blood vessels
at the extensor carpi radialis brevis muscle origin of man. Cells
Tiss Org 1999;165:45
554
- Jozsa LKP. Human Tendon: Anatomy, Physiology and
Pathology. Champaign: Human Kinetics,1997
- Kvist M. Achilles tendon injuries in athletes. Ann Chir
Gynaecol 1991;80:188
201[Medline]
- Leppilahti JOS, Karpakka J, et al. Overuse injuries of the
Achilles tendon. Ann Chir Gynaecol1991; 80:202
7[Medline]
- Komi PV, Fukashiro S, Jarvinen M. Biomechanical loading of Achilles
tendon during normal locomotion. Clin Sports Med1992; 11:521
31[Medline]
- Khan KM, Maffulli N. Tendinopathy: an Achilles heel for
athletes and clinicians. Clin J Sport Med1998; 8:151
4[Medline]
- Williams JG. Achilles tendon lesions in sport. Sports
Med 1986;3:114
35[Medline]
- Benazzo FMN. An operative approach to Achilles tendinopathy.
Sports Med Arthrosc Rev2000; 8:96
1001
- Leadbetter WB. Cell-matrix response in tendon injury.
Clin Sports Med1992; 11:533
78[Medline]
- Bestwick CSMN. Reactive oxygen species and tendon problems: review
and hypothesis. Sports Med Arthrosc Rev2000; 8:6
16
- Sullo A, Maffulli N, Capasso G, Testa V. The effects of prolonged
peritendinous administration of PGE1 to the rat Achilles tendon: a possible
animal model of chronic Achilles tendinopathy. J Orthopaed
Sci 2001;6:349
57[Medline]
- Corps AN, Curry VA, Harrall RI, Dutt D, Hazleman BL, Riley GP.
Ciprofloxacin reduces the stimulation of prostaglandin E(2) output by
interleukin-1beta in human tendon-derived cells. Rheumatology
(Oxford) 2003;42:1306
10
- Ireland D, Harrall R, Curry V, et al. Multiple changes in
gene expression in chronic human Achilles tendinopathy. Matrix
Biol 2001;20:159
69[Medline]
- Alfredson H, Lorentzon M, Backman S, Backman A, Lerner UH.
cDNA-arrays and real-time quantitative PCR techniques in the investigation of
chronic Achilles tendinosis. J Orthopaed Res2003; 21:970
5[Medline]
- Khan KM, Cook J, Maffulli N, Kannus P. Where is the pain coming
from in tendinopathy? It may be biochemical, not only structural, in origin.
Br J Sports Med2000; 34:81
3[Free Full Text]
- Khan KM, Cook J. Overuse tendon injuries: where does the pain come
from? Sports Med Arthrosc Rev2000; 8:17
31
- Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. Histopathology of
common tendinopathies. Update and implications for clinical management.
Sports Med1999; 27:393
408[Medline]
- Alfredson H, Thorsen K, Lorentzon R. In situ microdialysis
in tendon tissue: high levels of glutamate, but not prostaglandin E2 in
chronic Achilles tendon pain. Knee Surg Sports Traumatol
Arthroscopy 1999;7:378
81[Medline]
- Ackermann WPR. Sensory neuropeptides in achilles tendinosis.
Int Soc Arthroscopy Knee Surg Orthopaed Sports Med2001; 17:516
- Yaksh TL. Substance P release from knee joint afferent terminals:
modulation by opioids. Brain Res1988; 458:319
24[Medline]
- Maffulli N, Khan KM, Puddu G. Overuse tendon conditions. Time to
change a confusing terminology. Arthroscopy1998; 14:840
3[Medline]
- Maffulli N, Barrass V, Ewen SW. Light microscopic histology of
achilles tendon ruptures. A comparison with unruptured tendons.
Sports Med2000; 28:857
63
- Almekinders LC, Temple JD. Etiology, diagnosis, and treatment of
tendonitis: an analysis of the literature. Medicine Sci Sports
Exercise 1998;30:1183
90
- Nelen G, Burssens A. Surgical treatment of chronic Achilles
tendinitis. Am J Sports Med1989; 17:754
9[Abstract/Free Full Text]
- Clancy WGJ, Brand RL. Achilles tendonitis in runners: a report of
five cases. Am J Sports Med1976; 4:46
57[Free Full Text]
- Maffulli N, Regine R, Angelillo M, Capasso G, Filice S. Ultrasound
diagnosis of Achilles tendon pathology in runners. Br J Sports
Med 1987;21:158
62[Abstract/Free Full Text]
- Archambault JM, Wiley JP, Bray RC et al. Can sonography
predict the outcome in patients with achillodynia? J Clin
Ultrasound 1998;26:335
9[Medline]
- Schepsis AA, Leach RE. Surgical management of Achilles tendon
overuse injuries: a long-term follow-up study. Am J Sports
Med 1994;22:611
19[Abstract/Free Full Text]
- Paavola MKP, Paakkala T, Pasanen M, Järvinen M. Long-term
prognosis of patients with Achilles tendinopathy. An observational 8-year
follow-up study. Am J Sports Med2000; 28:634
42[Abstract/Free Full Text]
- Kvist H, Kvist M. The operative treatment of chronic calcaneal
paratenonitis. J Bone Joint Surg1980; 62B:353
7
- Clement DB, Taunton J, Smart GW. Achilles tendinitis and
peritendinitis: etiology and treatment. Am J Sports
Med 1984;12:179
84[Abstract/Free Full Text]
- Maffulli N, Binfield P, Moore D, et al. Surgical
decompression of chronic central core lesions of the Achilles tendon.
Am J Sports Med1999; 27:747
52[Abstract/Free Full Text]
- Alfredson H, Lorentzon R. Chronic Achilles tendinosis.
Recommendations for treatment and prevention. Sports
Med 2000;29:135
46[Medline]
- Jackson BA, Schwane JA, Starcher BC. Effect of ultrasound therapy
on the repair of Achilles tendon injuries in rats. Med Sci Sports
Exercise 1991;23:171
6[Medline]
- Ramirez A, Schwane JA, McFarland C, Starcher B. The effect of
ultrasound on collagen synthesis and fibroblast proliferation in vitro.Med Sci Sports Exercise1997; 29:326
32[Medline]
- Gehlsen GM, Ganion LR, Helfst R. Fibroblast responses to variation
in soft tissue mobilization pressure. Med Sci Sports
Exercise 1999;31:531
5[Medline]
- Silbernagel KG, Thomee R, Thomee P, Karlsson J. Eccentric overload
training for patients with chronic Achilles tendon paina randomized
controlled study with reliable testing of the evaluating methods.
Scand J Sports Med2001; 11:197
206[Medline]
- Gross ML, Davlin L, Evanski PM. Effectiveness of orthotic shoe
inserts in the long-distance runner. Am J Sports Med1991; 19:409
12[Abstract/Free Full Text]
- Capasso G, Maffulli N, Testa V, Sgambato A. Preliminary results
with peritendinous protease inhibitor injections in the management of Achilles
tendinitis. J Sports Traumatol Rel Res1993; 15:37
43
- Sundqvist H, Forsskahl B, Kvist M. A promising novel therapy for
Achilles peritendinitis: double-blind comparison of glycosaminoglycan
polysulfate and high-dose indomethacin. Int J Sports
Med 1987;8:298
303[Medline]
- Speed CA. Corticosteroid injections in tendon lesions.
BMJ2001; 323:82
6
- Friedrich T, Schmidt W, Jungmichel D, Horn LC, Josten C.
Histopathology in rabbit Achilles tendon after operative tenolysis
(longitudinal fiber incisions). Scand J Med Sci Sports2001; 11:4
8[Medline]
- Tallon C, Coleman BD, Khan KM, Maffuli N. Outcome of surgery for
chronic Achilles tendinopathy: a critical review. Am J Sports
Med 2001;29:315
20[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Rompe, J. Furia, and N. Maffulli
Eccentric Loading Compared with Shock Wave Treatment for Chronic Insertional Achilles Tendinopathy. A Randomized, Controlled Trial
J. Bone Joint Surg. Am.,
January 1, 2008;
90(1):
52 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R J de Vos, A Weir, R J A Visser, T. de Winter, and J L Tol
The additional value of a night splint to eccentric exercises in chronic midportion Achilles tendinopathy: a randomised controlled trial
Br. J. Sports Med.,
July 1, 2007;
41(7):
e5 - e5.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Rompe, B. Nafe, J. P. Furia, and N. Maffulli
Eccentric Loading, Shock-Wave Treatment, or a Wait-and-See Policy for Tendinopathy of the Main Body of Tendo Achillis: A Randomized Controlled Trial
Am. J. Sports Med.,
March 1, 2007;
35(3):
374 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ferns
Achilles tendinopathy
J R Soc Med,
December 1, 2004;
97(12):
608 - 608.
[Full Text]
[PDF]
|
 |
|